Details of the Drug Formulaction

General Information of Drug Formulation (ID: F02696)

• Formulation Name: Bosentan 125 mg tablet
• Company: Actelion Pharmaceuticals US

Pharmaceutical Drug(s) in Formulation

Drug Name	Drug ID	Indication	ICD 11	Status
Bosentan	(DMIOGBU)	Pulmonary arterial hypertension	BB01.0	Approved

Pharmaceutical Excipient(s) in Formulation

Excipient Name	Excipient ID	PubChem CID	Functional Classification
Eisenoxyd	(E00585)	56841934	Colorant
Ferric hydroxide oxide yellow	(E00539)	23320441	Colorant
Glyceryl dibehenate	(E00537)	22477175	Binding agent; Coating agent; Flavoring agent; Modified-release agent; Viscosity-controlling agent; lubricant
Magnesium stearate	(E00208)	11177	lubricant
Talc	(E00520)	16211421	Anticaking agent; Diluent; Glidant; lubricant
Titanium dioxide	(E00322)	26042	Coating agent; Colorant; Opacifying agent
Triacetin	(E00080)	5541	Humectant; Plasticizing agent; Solvent